Grouping variables | Categories of grouping variables (n) | IL-/7 Median (25–75%) | P value |
---|---|---|---|
Histological subtype | IDC (NST) (165) | 65.25 (29.4–166,0) | Kruskal–Wallis ANOVA test value H (2.0) = 6.30; P = 0.043 |
ILC (20) | 18.5 (6.9–150,3) | ||
Other (28) | 74.6 (23.4–148.0) | ||
Axillar involvement | Yes (86) | 70.9 (30.8–166.5) | Mann–Whitney adj z = 0.94; P = 0.348 |
No (127) | 58.8 (22.9–147.0) | ||
T-stage | T1 (103) | 59.0 (22.8–144.1) | Kruskal–Wallis ANOVA test value H = 0.3; P = 0.86 |
T2 (101) | 64.0 (25.1–166.7) | ||
T3 (9) | 57.9 (26.9–182.0) | ||
Stage | I (77) | 52.1 (19.2–134.3) | Kruskal–Wallis ANOVA test value H = 1.72; P = 0.42 |
II (97) | 63.6 (26–166.4) | ||
III (39) | 79.9 (23.9–169.3) | ||
Grade | I (13) | 42.4 (11.6–174.1) | Kruskal–Wallis ANOVA test value H (2.213) = 1.14; P = 0.57 |
II (138) | 62.4 (29.1–166.1) | ||
III (62) | 62.4 (16.8–129.2) | ||
ER | Positive (169) | 59.0 (23.9–159.3) | Mann–Whitney adj z = 0.53; P = 0.593 |
Negative (44) | 66.1 (20.0–168.2) | ||
PR | Positive (65) | 40.5 (11.7–110.9) | Mann–Whitney adj z = 0.96; P = 0.334 |
Negative (148) | 66.7 (29.9–168.1) | ||
Her-2 | Positive (40) | 66.8 (26.6–140.0) | Mann–Whitney adj z = 1.42; P = 0.672 |
Negative (172) | 61.1 (23.4–166.0) | ||
Molecular surrogate subtypes | LumA (77) | 71.1 (34.1–183.9) | Kruskal–Wallis ANOVA test value H (5.47) 4.0; P = 0.247 |
LumB/HER2 neg (75) | 51.1 (18.9–117.3) | ||
LumB/HER2 pos (20) | 52.6 (23.9–90.0) | ||
Her-2 overexpression (19) | 96.6 (43.9–225.3) | ||
TN (22) | 57.2 (17.9–151.0) | ||
LVI | Positive (85) | 62.6 (34.7–166.3) | Mann–Whitney adj z = 0.7; P = 0.484 |
Negative (128) | 62.4 (23.1–156.0) | ||
PNI | Positive (24) | 69.0 (37.9–166.8) | Mann–Whitney adj z = 0.87; P = 0.385 |
Negative (80) | 54.5 (22.9–158.1) |